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Supplementary Figure 1. Test molecules (ordered according to their molecular 
weight). Arrows indicate the site(s) targeted by chemo-enzymatic fluorination.  
O
2,3-dimethylcyclopent-2-enone
(1)
Natural product
Mol. Wt.: 110.1
O
Dihydrojasmone
(2)
Natural product
Mol. Wt.: 166.3
O
O
O
N
O
HO
O
O
O
O
O
O
O
O
O
O
O
O
O
O
Cl
C
O
O
O
O
C
O
O
O
O
O
O
N
N
O
O
Phenylbutazone
(31)
Antiinflammatory drug
Mol. Wt.: 308.3
N
N
H
N
O
S
O
O NH
O
NH
3-methyl-hexahydro-inden-1-one
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Supplementary Figure 2. Chiral GC traces of purified compound 5 (a) and 7 (b).  
 
 
Supplementary Figure 3. Chiral GC traces of purified compound 9 (a) and 10 (b). 
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Supplementary Figure 4. Chiral GC traces of purified compound 15 (a) and 18 (b). 
 
 
Supplementary Figure 5. Chiral GC traces of purified compound 19c (a) and 20c (b). 
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Supplementary Figure 6. Chiral GC traces of purified compound 21c (a), 22c (b), and 
23c (c). 
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Supplementary Figure 7. Membrane permeability properties of 12 and its fluorinated 
derivatives. Effective permeability values (Pe) are calculated by monitoring 
accumulation of the organic molecule in a cross-membrane compartment. The 
correlation between Pe value and BBB-permeability in the absence of active transport 
has been previously established using a wide set of commercial drugs2 and is illustrated 
by the graded bar (black = not BBB-permeable; white = BBB-permeable). Caffeine 
served as control for assay validation (literature: 1.30 x 10-6 cm s-1; experimental: 1.24 x 
10-6 cm s-1). M+/M- refers to the fraction of compound that crossed the BBB-mimic 
membrane as compared to system with no membrane after 16 hour incubation at room 
temperature. Values are means of three replicates. 
 
 
 
 
 
 
Nature Chemical Biology: doi: 10.1038/nchembio.128
 7 
 
Supplementary Table 1. Stereoselective fluorination of substituted 2-aryl acetic acid 
esters.  
 
Compound R1 R2 P450[a] mol% Yield (i)[b] Yield (ii)[b] ee[c] 
19a H Me var-A3 0.1 45% (19b) 75% (19c)  74% 
20a H Et var-B4 0.1 66% (20b) 78% (20c) 72% 
21a m-Cl Pr var-C12 0.05 75% (21b) 82% (21c) 89% 
22a o-Me  Pr var-C12 0.05 65% (22b) 83% (22c) 85% 
23a p-Me Pr var-C12 0.05 72% (23b) 88% (23c) 87% 
[a] The sequences of the P450 variants are reported in Supplementary Table 2. [b] Yields refer 
to the isolated product. [c] Enantiomeric excess determined by chiral GC analysis. 
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Supplementary Table 2. Sequences of the P450BM3 variants.  
Enzyme Amino acid mutations compared to wildtype P450BM3 
var-B2[a] V78A, H138Y, T175I, V178I, A184V, H236Q, E252G, R255S, A290V, 
A295T, L353V 
var-B3[b] R47C, V78A, K94I, P142S,T175I, A184V, F205C, S226R, H236Q, E252G, 
R255S, A290V, L353V 
var-B4 F87A 
var-C12[c] R47C, V78A, F87A, K94I, P142S,T175I, A184V, F205C, S226R, H236Q, 
E252G, R255S, A290V, L353V 
var-D10[c] R47C, V78A, A82L, K94I, P142S,T175I, A184V, F205C, S226R, H236Q, 
E252G, R255S, A290V, A328V, L353V 
var-G4[c] V78A, A82G, F87V, P142S,T175I, A184V, F205C, S226R, H236Q, 
E252G, R255S, A290V, A328V, L353V 
var-G5[c] V78A, F87I, P142S,T175I, A184V, F205C, S226R, H236Q, E252G, 
R255S, A290V, L353V 
var-G6[c] V78A, F81P, A82L, F87A, P142S, T175I, A180T, A184V, A197V, F205C, 
S226R, H236Q, E252G, R255S, A290V, L353V 
var-H1[d] R47C, L52I, V78F, A82S, K94I, P142S,T175I, A184V, F205C, S226R, 
H236Q, E252G, R255S, A290V, A328L, K349N, L353V, I366V, E464G, 
I710T 
var-H3[a] V78A, T175I, A184V, F205C, S226R, H236Q, E252G, R255S, A290V, 
L353V 
[a] var-B2 and var-H3 correspond, respectively, to variants 139-3 and J described in 
Fasan et al.4. 
[b] var-B3 corresponds to variant 9-10A described in Meinhold et al.5. 
[c] These variants are derivatives of variant var-B3. 
[d] var-H1 is a derivative of variant ETS8 described in Fasan et al.4. 
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Materials, Methods and Synthetic Procedures 
Reagents and Analytical Methods. Chemical reagents, substrates and solvents were 
purchased from Sigma-Aldrich, Acros Organics, Fluka, and Kaironkem. Silica gel 
chromatography purifications were carried out using AMD Silica Gel 60 230-400 mesh. 
Gas chromatography (GC) analyses were carried out using a Shimadzu GC-17A gas 
chromatograph, a FID detector, and an Agilent HP5 column (30 m x 0.32 mm x 0.1 μm 
film). Chiral GC analyses were carried out using a Shimadzu GC-17A gas 
chromatograph, a FID detector, and an Agilent Cyclosilb column (30 m x 0.52 mm x 
0.25 μm film). GC-MS analyses were carried out on a Hewlett-Packard 5970B MSD 
with 5890 GC and a DB-5 capillary column. HPLC analyses were carried out using a 
Waters 2690 instrument equipped with a 996 Photodiode Array Detector and a 
Phenomenex Gemini 5u C18 column. HPLC-MS analyses were carried out using an 
Agilent 1100 Series LC/MSD device and Kromasil 100, 5 um C18 column.  1H, 13C, and 
19F NMR spectra were recorded on a Varian Mercury 300 spectrometer (300 MHz, 75 
MHz, and 282 MHz, respectively), and are internally referenced to residual solvent 
peak. Data for 1H NMR are reported in the conventional form: chemical shift (δ ppm), 
multiplicity (s=singlet, d=doublet, t=triplet, q=quartet, m=multiplet, br=broad), 
coupling constant (Hz), integration). Data for 13C and 19F NMR are reported in the terms 
of chemical shift (δ ppm) and multiplicity. High-resolution mass spectra were obtained 
with a JEOL JMS-600H High Resolution Mass Spectrometer at the California Institute 
of Technology Mass Spectral Facility. 
 
Enzyme Library Screening. Expression of P450BM3 variants in 96-well plates and 
preparation of cell lysates were performed as described.1 Screening of enzyme activity 
on cyclopentenone derivatives (1, 2, and 3) and ibuprofen derivatives (12 and 16) was 
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carried out in 96-well microtiter plates mixing 700 μL KPi (100 mM, pH 8.0), 200 μL 
cell lysate, 10 μL 200 mM substrate in EtOH, and 100 μL of a cofactor regeneration 
solution containing 4 mM NADPH, 100 mM glucose-6-phosphate, and 10 U/mL 
glucose-6-phosphate dehydrogenase. After incubation for 16 hours at room temperature 
in orbital shaker, reactions were extracted with chloroform and analyzed by gas 
chromatography on a Shimadzu GC-17A GC using an Agilent HP5 column (30 m x 
0.32 mm x 0.1 μm film), 1 μL injection, FID detector, and the following separation 
method: 300 °C inlet, 300 °C detector, 70 °C oven, 10 °C/min gradient to 210 °C, 
50 °C/min gradient to 260 °C, and 260 °C for 2 min. Screening of enzyme activity on 
dihydro-4-methoxymethyl-2-methyl-5-phenyl-2-oxazoline (24) was carried out on 
microtiter plates by mixing 100 μL KPi (100 mM, pH 8.0), 50 μL cell lysate, 2 μL 200 
mM 24 in DMSO, and 50 μL KPi 4 mM NADPH. Reaction mixtures were incubated for 
30 minutes at room temperature and then added with 50 μL 150 mM Purpald in 2 M 
NaOH. Absorbance at 550 nm was recorded after 30 minutes. The most active variants 
identified in the colorimetric screen were re-tested for selectivity towards 
demethylation. 1-mL scale reactions were carried out using 1 mM 24, 0.5 μM P450, 400 
μM NADPH, 10 mM glucose-6-phosphate and 1 U/mL glucose-6-phosphate 
dehydrogenase. After stirring for 16 hours at room temperature, the reaction mixtures 
were extracted with chloroform and analyzed by GC-MS on a Hewlett-Packard 5970B 
MSD with 5890 GC using a DB-5 capillary column, 1 μL injection, 250 °C inlet, and 
the following separation program: 80 °C oven, 10 °C/min gradient to 250 °C, 250 °C for 
3 min. Enzyme activity on 27a, 28a, and 29a was screened by mixing 50 μL cell lysate, 
100 μL 100 mM KPi buffer (pH 8.0) containing 1 mM substrate (1% DMSO), and 50 
μL 4 mM NADPH in microtiter plates. After 30 min, 50 μL 150 mM Purpald (Sigma) 
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in 2 M NaOH were added to each well. Absorbance at 550 nm was measured after 60 
minutes. The most active variants were re-tested at 1-mL scale using 1 mM substrate, 
0.5 μM purified P450, and the cofactor regeneration system described above. After 
overnight incubation at 4 °C, reactions were analyzed by HPLC-MS using an Agilent 
1100 Series LC/MSD device and Kromasil 100, 5 μm-C18 column.  
 
Membrane permeability assay. The membrane permeability assays were carried out 
adapting a described procedure2 and using 96-well MultiScreen-IP plates from 
Millipore. Filter plates were rinsed with 70% EtOH and double-distilled water prior to 
use. BBB-mimic membranes were prepared by coating filter wells with 5 µL porcine 
brain lipids (PBL, Avanti Polar Lipids) in dodecane (20 mg/mL). Control wells (PBL-
free) were primed in the same way but not coated with PBL. Working solutions 
contained 0.5 mg/mL fluorinated compound in PBS pH 7.4 (5% EtOH). Assembled 
plates contained 150 µL working solution in the PBL-coated (or PBL-free) well, 300 µL 
PBS (5% EtOH) in the acceptor well, and were incubated at room temperature and 
100% humidity. The change in organic compound concentration in the donor and 
acceptor wells was monitored over time by HPLC. Membrane permeability values (Pe) 
were calculated as described.3 All measurements were performed in triplicates. The 
assay was validated by comparing our experimental Pe value for caffeine with that 
reported by Wohnsland et al.3. 
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Synthetic procedures: 
 
Conversion of 1 to 5. 130 mg (1.18 mmol) 1 were dissolved in 1.5 mL ethanol and 
added to 200 mL potassium phosphate buffer pH 8.0. The solution was added with var-
H3 (final conc.: 2.5 μM) and a cofactor regeneration system (final conc.: 500 μM 
NADPH, 30 mM glucose-6-phosphate, 1 unit/mL glucose-6-phosphate dehydrogenase) 
and stirred at room temperature. After 48 hours, the reaction mixture was extracted with 
dichloromethane (4 x 50 mL). The combined organic phases were dried over anhydrous 
Na2SO4 and evaporated under reduced pressure. The residue was purified by flash 
chromatography (gradient 0 to 20% ethyl acetate in hexane) to afford 1a (130 mg, 88%, 
colorless oil). 1H-NMR (300 MHz, CDCl3): δ 1.71 (m, 3H, CH3), δ 2.08 (m, 3H, CH3), 
δ 2.27 (dd, J= 18.3, 1.8 Hz, 1H), δ 2.77 (dd, J= 18.3, 6.3 Hz, 1H), δ 4.73 (m, 1H). 13C-
NMR (75 MHz, CDCl3): δ 8.18, δ 13.91, δ 44.44, δ 71.85, δ 138.37, δ 168.50, δ 205.96. 
HRMS (EI+): exact mass calculated for C7H10O2 requires m/z 126.0681, found 
126.0687. Under argon, 50 mg (0.22 mmol) 1a and a catalytic amount (3 drops) of 
ethanol were dissolved in 3 mL dry dichloromethane. The solution was cooled to -78 °C 
and added with 38 μL DAST (0.26 mmol, 1.2 eq) in two aliquots. The reaction was 
stirred in dry ice for 12 hours. The reaction mixture was added with 5 mL saturated 
sodium bicarbonate and extracted with dichloromethane (3 x 15 mL). The organic phase 
was then dried over anhydrous magnesium sulfate and evaporated under reduced 
pressure. The residue was purified by flash chromatography (gradient 10% to 50% 
dichloromethane in pentane) to afford 5 (25 mg, 90% yield, colorless oil). 1H-NMR 
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(300 MHz, CD2Cl2): δ 1.68 (dm, J= 4.2 Hz, 3H, CH3), δ 2.04 (m, 3H, CH3), δ 2.41 (tm, 
J= 20.7 1H), δ 2.63-2.76 (m, 1H), δ 5.48 (dm, J= 30.6 Hz, 1H). 13C-NMR (75 MHz, 
CD2Cl2): δ 7.83, δ 13.40, δ 41.21 (d, J= 19.9 Hz), δ 91.59 (d, J= 173.7 Hz), δ 128.03. 
19F-NMR (282 MHz, CD2Cl2): δ -179.4 (dd, J= 51.6, 24.2 Hz). HRMS (EI+): exact 
mass calculated for C7H9FO requires m/z 128.0637, found 128.0642. Chiral GC 
analyses were carried out using a Shimadzu GC-17A gas chromatograph, FID detector, 
Agilent Cyclosilb column (30 m x 0.52 mm x 0.25 μm film) and the following 
separation program: 300 °C inlet, 300 °C detector, 60 °C oven, 0.5 °C/min gradient to 
200 °C, 50 °C/min gradient to 250 °C, and 250 °C for 2 min. An enantiomeric excess of 
22% was estimated based on peak areas (see Supplementary Figure 2). 
 
Conversion of 1 to 6. 130 mg (1.18 mmol) 1 were dissolved in 1.5 mL ethanol and 
added to 200 mL potassium phosphate buffer pH 8.0. The solution was added with var-
G6 (final conc.: 2.5 μM) and a cofactor regeneration system (final conc.: 500 μM 
NADPH, 30 mM glucose-6-phosphate, 1 unit/mL glucose-6-phosphate dehydrogenase) 
and stirred at room temperature. After 48 hours, the reaction mixture was extracted with 
dichloromethane (4 x 50 mL). The combined organic phases were dried over anhydrous 
Na2SO4 and evaporated under reduced pressure. The residue was purified by flash 
chromatography (gradient 0 to 20% ethyl acetate in hexane) to afford 1c (66 mg, 45%, 
colorless oil). 1H-NMR (300 MHz, CDCl3): δ 1.71 (m, 3H, CH3), δ 2.4 (dm, J= 4.5 Hz, 
2H), δ 2.65 (m, 2H), δ 4.58 (s, 2H). 13C-NMR (75 MHz, CDCl3): δ 8.23, δ 27.18, δ 
34.10, δ 61.05, δ 136.15, δ 170.05, δ 210.61. HRMS (EI+): exact mass calculated for 
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C7H10O2 requires m/z 126.0681, found 126.0685. Under argon, 50 mg (0.22 mmol) 1c 
and a catalytic amount (3 drops) of ethanol were dissolved in 3 mL dry 
dichloromethane. The solution was cooled to -78 °C and added with 38 μL DAST (0.26 
mmol, 1.2 eq) in two aliquots. The reaction was stirred in dry ice for 12 hours. The 
reaction mixture was added with 5 mL saturated sodium bicarbonate and extracted with 
dichloromethane (3 x 15 mL). The organic phase was then dried over anhydrous 
magnesium sulfate and evaporated under reduced pressure. The residue was purified by 
flash chromatography (gradient 10% to 50% dichloromethane in pentane) to afford 6 
(24 mg, 85% yield, colorless oil). 1H-NMR (300 MHz, CD2Cl2): δ 1.67 (m, 3H, CH3), δ 
2.36 (m, 2H), δ 2.56 (m, 2H), δ 5.23 (d, J= 34.2 Hz, 2H). 13C-NMR (75 MHz, CD2Cl2): 
δ 7.95, δ 26.41 (d, J= 4.3 Hz), δ 80.83 (d, J= 164.0 Hz). 19F-NMR (282 MHz, CD2Cl2): 
δ -226.9 (t, J= 42.3 Hz). HRMS (EI+): exact mass calculated for C7H9FO requires m/z 
128.0637, found 128.0643. 
 
Conversion of 2 to 7. 270 mg (1.62 mmol) 2 were dissolved in 2.5 mL ethanol and 
added to 250 mL potassium phosphate buffer pH 8.0. The solution was added with var-
H3 (final conc.: 3 μM) and a cofactor regeneration system (final conc.: 500 μM 
NADPH, 30 mM glucose-6-phosphate, 1 unit/mL glucose-6-phosphate dehydrogenase) 
and stirred at room temperature. After 48 hours, the reaction mixture was extracted with 
dichloromethane (4 x 50 mL). The combined organic phases were dried over anhydrous 
Na2SO4 and evaporated under reduced pressure. The residue was purified by flash 
chromatography (gradient 0 to 30% ethyl acetate in hexane) to afford 2a (250 mg, 85%, 
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pale yellow oil). 1H-NMR (300 MHz, CDCl3): δ 0.87 (t, J= 6.9 Hz, 3H, CH3), δ 1.25-
1.39 (m, 6H), δ 2.08 (s, 3H, CH3), δ 2.17 (t, J= 8.1 Hz, 2H), δ 2.27 (dd, J= 18.3, 2.1 Hz, 
1H), δ 2.77 (dd, J= 18.3, 6.3 Hz, 1H), δ 4.72 (dm, J= 5.1 Hz, 1H). 13C-NMR (75 MHz, 
CDCl3): δ 13.83, δ 14.22, δ 22.68, δ 23.16, δ 28.06, δ 28.06, δ 31.99, δ 44.60, δ 71.87, δ 
142.73, δ 168.32, δ 205.59. HRMS (EI+): exact mass calculated for C11H18O2 requires 
m/z 182.1307, found 182.1311. Under argon, 200 mg (1.09 mmol) 2a and a catalytic 
amount (4 drops) of ethanol were dissolved in 5 mL dry dichloromethane. The solution 
was cooled to -78 °C and added with 200 μL DAST (1.4 mmol, 1.3 eq) in four aliquots. 
The reaction was stirred in dry ice for 12 hours. The reaction mixture was added with 7 
mL saturated sodium bicarbonate and extracted with dichloromethane (3 x 20 mL). The 
organic phase was then dried over anhydrous magnesium sulfate and evaporated under 
reduced pressure. The residue was purified by flash chromatography (gradient 0 to 30% 
ethyl acetate in hexane) to afford 7 (193 mg, 92% yield, pale yellow oil). 1H-NMR (300 
MHz, CDCl3): δ 0.88 (t, J= 6.6 Hz, 3H, CH3), δ 1.25-1.40 (m, 6H), δ 2.10 (d, J= 2.1 Hz, 
2H, CH3), δ 2.20 (t, J= 7.1 Hz, 2H), δ 2.51 (tm, J= 22.5 Hz, 1H), δ 2.70-2.82 (m, 1H), δ 
5.47 (dd, J= 53.7, 6.0, 1H). 13C-NMR (75 MHz, CDCl3): δ 13.75, δ 14.21, δ 22.66, δ 
23.13, δ 27.90, δ 29.94, δ 31.96, δ 41.46 (d, J= 19.6 Hz), δ 91.42 (d, J= 174.9 Hz), δ 
167.62. 19F-NMR (282 MHz, CDCl3): δ -179.1 (ddd, J= 51.8, 21.4, 9.3 Hz). HRMS 
(EI+): exact mass calculated for C11H17FO requires m/z 184.1263, found 184.1255. 
Chiral GC analyses were carried out using a Shimadzu GC-17A gas chromatograph, 
FID detector, Agilent Cyclosilb column (30 m x 0.52 mm x 0.25 μm film) and the 
following separation program: 300 °C inlet, 300 °C detector, 70 °C oven, 1 °C/min 
gradient to 200 °C, 50 °C/min gradient to 250 °C, and 250 °C for 2 min. An 
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enantiomeric excess of 78% was estimated based on peak areas (see Supplementary 
Figure 2). 
O O O
2 2c 8
OH F
 
Conversion of 2 to 8. 100 mg (0.60 mmol) 2 were dissolved in 1 mL ethanol and added 
to 150 mL potassium phosphate buffer pH 8.0. The solution was added with var-G4 
(final conc.: 2 μM) and a cofactor regeneration system (final conc.: 500 μM NADPH, 
30 mM glucose-6-phosphate, 1 unit/mL glucose-6-phosphate dehydrogenase) and 
stirred at room temperature. After 48 hours, the reaction mixture was extracted with 
dichloromethane (3 x 50 mL). The combined organic phases were dried over anhydrous 
Na2SO4 and evaporated under reduced pressure. The residue was purified by flash 
chromatography (gradient 0 to 30% ethyl acetate in hexane) to afford 2c (46 mg, 42%, 
pale yellow oil). GC-MS (EI+): m/z 182. Under argon, 46 mg (0.25 mmol) 2c and a 
catalytic amount (2 drops) of ethanol were dissolved in 2.5 mL dry dichloromethane. 
The solution was cooled to -78 °C and added with 54 μL DAST (0.38 mmol, 1.5 eq) in 
two aliquots. The reaction was stirred in dry ice for 12 hours. The reaction mixture was 
added with 5 mL saturated sodium bicarbonate and extracted with dichloromethane (3 x 
15 mL). The organic phase was then dried over anhydrous magnesium sulfate and 
evaporated under reduced pressure. The residue was purified by flash chromatography 
(gradient 0 to 30% ethyl acetate in hexane) to afford 8 (62 mg, 89% yield, pale yellow 
oil). 1H-NMR (300 MHz, CDCl3): δ 0.87 (t, J= 6.5 Hz, 3H, CH3), δ 1.23-1.38 (m, 6H), δ 
2.17 (t, J= 7.5 Hz, 2H), δ 2.41 (m, 1H), δ 2.60 (m, 1H), δ 5.26 (d, J= 47.1, 1H). 13C-
NMR (75 MHz, CDCl3): δ 14.32, δ 22.86, δ 23.33, δ 28.46, δ 31.80, δ 31.93, δ 34.87, δ 
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80.37 (d, J= 164.8 Hz). 19F-NMR (282 MHz, CDCl3): δ -227.9 (t, J= 48.2 Hz). HRMS 
(EI+): exact mass calculated for C11H17FO requires m/z 184.1263, found 184.1263. 
 
Conversion of 3 to 9. 230 mg (1.53 mmol) 3 were dissolved in 2 mL ethanol and added 
to 300 mL potassium phosphate buffer pH 8.0. The solution was added with var-D10 
(final conc.: 2.5 μM) and a cofactor regeneration system (final conc.: 500 μM NADPH, 
30 mM glucose-6-phosphate, 1 unit/mL glucose-6-phosphate dehydrogenase) and 
stirred at room temperature. After 48 hours, the reaction mixture was extracted with 
dichloromethane (4 x 80 mL). The combined organic phases were dried over anhydrous 
Na2SO4 and evaporated under reduced pressure. The residue was purified by flash 
chromatography (gradient 0 to 20% ethyl acetate in hexane) to afford 3a (175 mg, 69%, 
colorless oil). GC-MS (EI+): m/z 166. Under argon, 100 mg (0.60 mmol) 3a and a 
catalytic amount (3 drops) of ethanol were dissolved in 5 mL dry dichloromethane. The 
solution was cooled to -78 °C and added with 103 μL DAST (0.72 mmol, 1.2 eq) in two 
aliquots. The reaction was stirred in dry ice for 3 hours. The reaction mixture was added 
with 5 mL saturated sodium bicarbonate and extracted with dichloromethane (3 x 20 
mL). The organic phase was then dried over anhydrous magnesium sulfate and 
evaporated under reduced pressure. The residue was purified by flash chromatography 
(10% ethyl acetate : 90% hexane) to afford 9 (89 mg, 88% yield, colorless oil). 1H-
NMR (300 MHz, CDCl3): δ 1.84 (d, J= 6.6 Hz), δ 1.45-1.75 (m, 2H), δ 1.80-1.86 (m, 
2H), δ 2.03 (m, 1H), δ 2.06 (dd, J= 18.4, 1.8 Hz, 1H), δ 2.13-2.21 (m, 1H), δ 2.65 (dd, 
J=18.4,6.9 Hz, 1H), δ 2.80 (m, 1H), δ 5.28 (dbr, J= 50.1 Hz, 1H). 13C-NMR (75 MHz, 
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CDCl3): δ 14.47, δ 18.78, δ 25.89, δ 28.67 (d, J=21.9 Hz), δ 36.29, δ 43.89, δ 79.93 (d, 
J= 164.2 Hz), δ 135.71 (d, J= 17.9 Hz), δ 183.76 (d, J= 5.6 Hz), δ 206.26. 19F-NMR 
(282 MHz, CDCl3): δ -171.4 (m). HRMS (EI+): exact mass calculated for C10H13FO 
requires m/z 168.0950, found 168.0908. Chiral GC analyses were carried out using a 
Shimadzu GC-17A gas chromatograph, FID detector, Agilent Cyclosilb column (30 m x 
0.52 mm x 0.25 μm film) and the following separation program: 300 °C inlet, 300 °C 
detector, 70 °C oven, 1 °C/min gradient to 200 °C, 50 °C/min gradient to 250 °C, and 
250 °C for 2 min. A diasteromeric ratio (dr) of 1:8.5, an enantiomeric excess of 5% for 
the major product, and an enantiomeric excess of 71% for the minor product were 
estimated based on peak areas (see Supplementary Figure 3). 
 
Conversion of 3 to 10. 200 mg (1.33 mmol) 3 were dissolved in 1.5 mL ethanol and 
added to 200 mL potassium phosphate buffer pH 8.0. The solution was added with var-
G4 (final conc.: 3.5 μM) and a cofactor regeneration system (final conc.: 500 μM 
NADPH, 30 mM glucose-6-phosphate, 1 unit/mL glucose-6-phosphate dehydrogenase) 
and stirred at room temperature. After 36 hours, the reaction mixture was extracted with 
dichloromethane (4 x 80 mL). The combined organic phases were dried over anhydrous 
Na2SO4 and evaporated under reduced pressure. The residue was purified by flash 
chromatography (30% ethyl acetate in hexane) to afford 3b (137 mg, 62%, colorless 
oil). GC-MS (EI+): m/z 166. Under argon, 50 mg (0.30 mmol) 3b and a catalytic amount 
(3 drops) of ethanol were dissolved in 3 mL dry dichloromethane. The solution was 
cooled to -78 °C and added with 51 μL DAST (0.36 mmol, 1.2 eq) in two aliquots. The 
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reaction was stirred in dry ice for 5 hours. The reaction mixture was added with 5 mL 
saturated sodium bicarbonate and extracted with dichloromethane (3 x 15 mL). The 
organic phase was then dried over anhydrous magnesium sulfate and evaporated under 
reduced pressure. The residue was purified by flash chromatography (10% ethyl acetate 
: 90% hexane) to afford 10 (46 mg, 92% yield, colorless oil). 1H-NMR (300 MHz, 
CDCl3): δ 1.27 (d, J= 6.9 Hz, 3H), δ 1.71-1.79 (m, 3H), δ 2.02 (dbr, J= 18.6, 1H), δ 2.03 
(br, 1H), δ 2.10-2.13 (m, 1H), δ 2.23-2.35 (m, 1H), δ 2.67 (dd, J=18.6,6.3 Hz, 1H), δ 
2.92 (br, 1H), δ 5.20 (dbr, J= 46.2 Hz, 1H). 13C-NMR (75 MHz, CDCl3): δ 17.55, δ 
19.96, δ 20.18 (d, J= 2.8 Hz), δ 29.80 (d, J=21.3 Hz), δ 36.12, δ 44.32, δ 86.48 (d, J= 
166.5 Hz), δ 142.79, δ 168.15 (d, J= 13.9 Hz), δ 208.86. 19F-NMR (282 MHz, CDCl3): δ 
-174.8 (m). HRMS (EI+): exact mass calculated for C10H13FO requires m/z 168.0950, 
found 168.0913. Chiral GC analyses were carried out using a Shimadzu GC-17A gas 
chromatograph, FID detector, Agilent Cyclosilb column (30 m x 0.52 mm x 0.25 μm 
film) and the following separation program: 300 °C inlet, 300 °C detector, 70 °C oven, 
1 °C/min gradient to 200 °C, 50 °C/min gradient to 250 °C, and 250 °C for 2 min. A 
diasteromeric ratio (dr) of 4:96 and an enantiomeric excess of 57% for minor product 
were estimated based on peak areas (see Supplementary Figure 3).  
 
Conversion of 3 to 11. 150 mg (1.0 mmol) 3 were dissolved in 1.5 mL ethanol and 
added to 200 mL potassium phosphate buffer pH 8.0. The solution was added with var-
G5 (final conc.: 3.5 μM) and a cofactor regeneration system (final conc.: 500 μM 
NADPH, 30 mM glucose-6-phosphate, 1 unit/mL glucose-6-phosphate dehydrogenase) 
Nature Chemical Biology: doi: 10.1038/nchembio.128
 20 
 
and stirred at room temperature. After 36 hours, the reaction mixture was extracted with 
dichloromethane (4 x 80 mL). The combined organic phases were dried over anhydrous 
Na2SO4 and evaporated under reduced pressure. The residue was purified by flash 
chromatography (30% ethyl acetate in hexane) to afford 3c (53 mg, 32%, colorless oil). 
GC-MS (EI+): m/z 166. Under argon, 53 mg (0.32 mmol) 3c and a catalytic amount (3 
drops) of ethanol were dissolved in 3 mL dry dichloromethane. The solution was cooled 
to -78 °C and added with 51 μL DAST (0.36 mmol, 1.2 eq) in two aliquots. The reaction 
was stirred in dry ice for 5 hours. The reaction mixture was added with 5 mL saturated 
sodium bicarbonate and extracted with dichloromethane (3 x 15 mL). The organic phase 
was then dried over anhydrous magnesium sulfate and evaporated under reduced 
pressure. The residue was purified by flash chromatography (10% ethyl acetate : 90% 
hexane) to afford 11 (48 mg, 90% yield, colorless oil). 1H-NMR (300 MHz, CDCl3): δ 
1.18 (d, J= 7.2 Hz, 3H), δ 1.45-1.64 (m, 1H), δ 1.79-1.86 (m, 2H), δ 2.00 (dd, J= 18.6, 
3.9 Hz, 1H), δ 2.11-2.24 (m, 1H), δ 2.33-2.37 (m, 1H), δ 2.67 (dd, J= 18.6, 6.3 Hz, 1H), 
δ 2.86 (m, 1H), δ 5.29 (dm, J= 50.1 Hz, 1H). 13C-NMR (75 MHz, CDCl3): δ 17.36, δ 
18.62, δ 26.58, δ 28.74 (d, J= 20.7 Hz), δ 37.08, δ 43.67, δ 79.82 (d, J= 164.2 Hz), δ 
135.65, δ 208.57. 19F-NMR (282 MHz, CDCl3): δ -170.5 (m). HRMS (EI+): exact mass 
calculated for C10H13FO requires m/z 168.0950, found 168.0923. Chiral GC analyses 
were carried out using a Shimadzu GC-17A gas chromatograph, FID detector, Agilent 
Cyclosilb column (30 m x 0.52 mm x 0.25 μm film). Complete separation of all four 
diasteromers was not possible. 
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Conversion of 12 to 15. 1.4 mL DMSO containing 150 mg (0.68 mmol) 12 were 
dissolved in 150 mL 100 mM KPi pH 8.0. The solution was added with var-B4 (final 
conc.: 4.5 μM) and a cofactor regeneration system (final conc.: 1 mM NADPH, 30 mM 
glucose-6-phosphate, 1 unit/mL glucose-6-phosphate dehydrogenase) and stirred at 
room temperature. After 48 hours, the reaction mixture was extracted with 
dichloromethane (4 x 50 mL). The combined organic phases were dried over anhydrous 
Na2SO4 and evaporated under reduced pressure. The residue was purified by flash 
chromatography (gradient from 5 to 40% ethyl acetate in hexane) to afford 13 (114 mg, 
72%, colorless oil). 1H-NMR (300 MHz, CDCl3): δ 0.78 (d, J= 6.9 Hz, 3H, CH3), δ 0.98 
(d, J= 6.9 Hz, 3H, CH3), δ 1.48 (d, J= 6.9 Hz, 3H, CH3), δ 1.85-2.00 (m, 1H, CH), δ 
3.65 (s, 3H, OCH3), δ 3.72 (q, J= 6.9 Hz, 1H, CH), δ 4.33 (d, J= 6.9 Hz, 1H, CH), δ 7.25 
(m, 4H, CH). 13C-NMR (75 MHz, CDCl3): δ 18.43, δ 18.81, δ 19.26, δ 35.42, δ 45.32, δ 
52.27, δ 79.99, δ 127.09, δ 127.52, δ 139.86, δ 142.77, δ 175.27. HRMS (EI+): exact 
mass calculated for C14H20O3 requires m/z 236.1412, found 236.1415. Under argon, 40 
mg (0.17 mmol) 13 and a catalytic amount of ethanol were dissolved in 4 mL dry 
dichloromethane. The solution was cooled to -78 °C. After 5 minutes, 29 μL DAST 
(0.24 mmol, 1.4 eq) were added to the mixture. The reaction was stirred in dry ice 
overnight. The reaction was then added with 5 mL saturated sodium bicarbonate  and 
extracted with dichloromethane (3 x 15 mL). The organic phase was then dried over 
anhydrous Na2SO4 and evaporated under reduced pressure. The residue was purified by 
flash chromatography (5% ethyl acetate : 95% hexane) to afford 15 (35 mg, 86% yield, 
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colorless oil). 1H-NMR (300 MHz, CDCl3): δ 0.84 (d, J= 6.3 Hz, 3H, CH3), δ 1.01 (d, 
J= 5.7 Hz, 3H, CH3), δ 1.48 (d, J= 6.9 Hz, 3H, CH3), δ 2.05-2.18 (m, 1H, CH), δ 3.66 (s, 
3H, OCH3), δ 3.72 (q, J= 7.5 Hz, 1H, CH), 5.07 (dd, J= 40.0, J= 6.9 Hz, 1H, CHF), δ 
7.25 (m, 4H, CH). 13C-NMR (75 MHz, CDCl3): δ 17.78 (d, J= 5.1 Hz), δ 18.58 (d, J= 
6.0 Hz), δ 18.81, δ 34.48 (d, J: 85.7 Hz), δ 45.37, δ 52.31, δ 99.3 (d, J= 174 Hz), δ 
126.65, δ 126.75, δ 127.56, δ 138.37, δ 140.6, δ 175.16. 19F-NMR (282 MHz, CDCl3): δ 
-179.8 (m). HRMS (EI+): exact mass calculated for C14H19FO2 requires m/z 238.1369, 
found 238.1367. Chiral GC analyses were carried out using a Shimadzu GC-17A gas 
chromatograph, FID detector, Agilent Cyclosilb column (30 m x 0.52 mm x 0.25 μm 
film) and the following separation program: 300 °C inlet, 300 °C detector, 70 °C oven, 
1 °C/min gradient to 200 °C, 50 °C/min gradient to 250 °C, and 250 °C for 2 min. A 
diasteromeric ratio (dr) of 1:3.2, an enantiomeric excess of 19% for the major product, 
and an enantiomeric excess of 44% for the minor product were estimated based on peak 
areas (see Supplementary Figure 4).  
 
 
Conversion of 12 to 16. 2.5 mL DMSO containing 220 mg (1 mmol) 12 were dissolved 
in 250 mL 100 mM KPi pH 8.0. The solution was added with var-G4 (final conc.: 2 
μM) and a cofactor regeneration system (final conc.: 500 μM NADPH, 30 mM glucose-
6-phosphate, 1 unit/mL glucose-6-phosphate dehydrogenase) and stirred at room 
temperature. After 48 hours, the reaction mixture was extracted with dichloromethane 
(4 x 80 mL). The combined organic phases were dried over anhydrous Na2SO4 and 
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evaporated under reduced pressure. The residue was purified by flash chromatography 
(gradient from 5 to 40% ethyl acetate in hexane) to afford 14 (208 mg, 88%, colorless 
oil). 1H-NMR (300 MHz, CDCl3): δ 1.21 (s, 6H, CH3), δ 1.48 (d, J= 7.2 Hz, 3H, CH3), δ 
2.73 (s, 2H, CH), δ 3.65 (s, 3H, OCH3), δ 3.70 (q, J= 7.2 Hz, 1H, CH), δ 7.15 (d, J= 8.1, 
2H, CH), δ 7.23 (d, J= 8.1, 2H, CH). 13C-NMR (75 MHz, CDCl3): δ 18.84, δ 29.41 
(2C), δ 45.26, δ 49.51, δ 52.29, δ 71.00, δ 127.53 (2C), δ 130.98 (2C), δ 136.82, δ 
138.92, δ 175.33. HRMS (EI+): exact mass calculated for C14H20O3 requires m/z 
236.1412, found 236.1413. Under argon, 120 mg (0.51 mmol) 14 and a catalytic amount 
of ethanol (3 drops) were dissolved in 6 mL dry dichloromethane. The solution was 
cooled to -78 °C. After 5 minutes, 87 μL DAST (0.61 mmol, 1.4 eq) were added to the 
mixture in three aliquots. The reaction was stirred in dry ice overnight. The reaction was 
then added with 8 mL saturated sodium bicarbonate and extracted with dichloromethane 
(3 x 20 mL). The organic phase was then dried over anhydrous Na2SO4 and evaporated 
under reduced pressure. The residue was purified by flash chromatography (5% ethyl 
acetate: 95% hexane) to afford 16 (114 mg, 95% yield, colorless oil). 1H-NMR (300 
MHz, CDCl3): δ 1.32 (d, J= 23.6 Hz, 6H, CH3), δ 1.48 (d, J= 6.9 Hz, 3H, CH3),  δ 2.87 
(d, J: 20.4 Hz, 2H), δ 3.65 (s, 3H, OCH3), δ 3.70 (q, J= 7.1 Hz, 1H), δ 7.15 (d, J= 8.1 
Hz, 2H, CH), δ 7.21 (d, J= 8.1 Hz, 2H, CH). 13C-NMR (75 MHz, CDCl3): δ 18.80, δ 
26.83 (d, J: 24.2 Hz), δ 45.24, δ 47.37 (d, J: 22.8 Hz), δ 52.25, δ 98.37 (d, J= 264 Hz), δ 
129.12 (d, J: 258.8 Hz), δ 127.39, δ 130.85, δ 136.07, δ 138.92, δ 175.31. 19F-NMR 
(282 MHz, CDCl3): δ -137.7 (m). HRMS (EI+): exact mass calculated for C14H19FO2 
requires m/z 238.1369, found 238.1370. 
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Conversion of 16 to 18. 2 mL DMSO containing 80 mg (0.33 mmol) 16 were dissolved 
in 200 mL 100 mM KPi pH 8.0. The solution was added with var-B2 (final conc.: 1 
μM) and a cofactor regeneration system (final conc.: 500 μM NADPH, 30 mM glucose-
6-phosphate, 1 unit/mL glucose-6-phosphate dehydrogenase) and stirred at room 
temperature. After 48 hours, the reaction mixture was extracted with dichloromethane 
(4 x 80 mL). The combined organic phases were dried over anhydrous Na2SO4 and 
evaporated under reduced pressure. The residue was purified by flash chromatography 
(5% ethyl acetate: 95% hexane) to afford 17 (78 mg, 93%, colorless oil). 1H-NMR (300 
MHz, CDCl3): δ 1.31 (d, J= 22.5 Hz, 3H, CH3), δ 1.32 (d, J= 22.5 Hz, 3H, CH3), δ 1.48 
(d, J= 7.2 Hz, 3H, CH3), δ 3.65 (s, 3H, OCH3), δ 3.72 (q, J= 7.2 Hz, 1H, CH), δ 4.69 (d, 
J= 11.7 Hz, 1H, CH), δ 7.26 (d, J= 8.1 Hz, 2H, CH), δ 7.34 (d, J= 8.1 Hz, 2H, CH). 13C-
NMR (75 MHz, CDCl3): δ 18.79, δ 21.55 (d, J= 23.1 Hz), δ 24.08 (d, J= 23.7 Hz), δ 
45.31, δ 52.28, δ 79.29 (d, J= 23.6 Hz), δ 98.14 (d, J= 168 Hz), δ 127.42, δ 127.91, δ 
138.28 (d, J= 5.7 Hz), δ 140.55, δ 175.12. 19F-NMR (282 MHz, CDCl3): δ -146.8 (m). 
HRMS (EI+): exact mass calculated for C14H20FO3 requires m/z 255.1396, found 
255.1394. Under argon, 30 mg (0.12 mmol) 17 and a catalytic amount of ethanol were 
dissolved in 3 mL dry dichloromethane. The solution was cooled to -78 °C. After 5 
minutes, 20 μL DAST (0.14 mmol, 1.2 eq) were added to the mixture. The reaction was 
stirred in dry ice overnight. The reaction was then added with 5 mL saturated sodium 
bicarbonate and extracted with dichloromethane (3 x 15 mL). The organic phase was 
then dried over anhydrous Na2SO4 and evaporated under reduced pressure. The residue 
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was purified by flash chromatography (5% ethyl acetate: 95% hexane) to afford 18 (30 
mg, 98% yield, colorless oil). 1H-NMR (300 MHz, CDCl3): δ 1.32 (m, 6H, CH3), δ 1.51 
(d, J= 7.2 Hz, 3H, CH3), δ 3.66 (s, 3H, OCH3), δ 3.74 (q, J= 7.2 Hz, 1H, CH), δ 5.29 
(dd, J= 45.0, 13.8 Hz, 1H, CHF), δ 7.31 (s, 4H, CH). 13C-NMR (75 MHz, CDCl3): δ 
18.80, δ 23.01 (m), δ 45.38, δ 52.34, δ 96.80 (d, J= 179 Hz), δ 96.52 (d, J= 179 Hz), δ 
127.50, δ 127.59, δ 134.8 (d, J= 22.5), δ 141.28, δ 175.03. 19F-NMR (282 MHz, 
CDCl3): δ -150.7 (m), δ -187.8 (dd, J= 45.6, 9.0 Hz). HRMS (EI+): exact mass 
calculated for C14H19F2O2 requires m/z 257.1353, found 257.1356. Chiral GC analyses 
were carried out using a Shimadzu GC-17A gas chromatograph, FID detector, Agilent 
Cyclosilb column (30 m x 0.52 mm x 0.25 μm film) and the following separation 
program: 300 °C inlet, 300 °C detector, 70 °C oven, 0.5 °C/min gradient to 200 °C, 
50 °C/min gradient to 250 °C, and 250 °C for 2 min. A diasteromeric ratio (dr) of 1:3.7, 
an enantiomeric excess of 9% for the major product, and an enantiomeric excess of 9% 
for the minor product were estimated based on peak areas (see Supplementary Figure 
4).  
 
Conversion of 19a to 19c. 90 mg (0.6 mmol) 19a were dissolved in 500 μL ethanol and 
added to 240 mL 100 mM KPi buffer pH 8.0. Var-A3 was added to the mixture at a 
final concentration of 2 μM. The mixture was added with a cofactor regeneration 
solution containing 0.5 mM NADPH, 30 mM glucose-6-phosphate and 1 U/mL 
glucose-6-phosphate dehydrogenase (final concentrations). The reaction mixtures were 
stirred at room temperature and extracted with chloroform (3 x 100 mL) after 4 hours. 
The organic phase was then dried over anhydrous MgSO4 and evaporated under reduced 
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pressure. Purification of the resulting oil by silica gel chromatography (5% ethyl acetate 
: 95% hexane) afforded 19b (45 mg). 45 mg (0.27 mmol) of 19b and a catalytic amount 
(3 drops) of ethanol were dissolved in 2 mL dry dichloromethane under argon. The 
solution was cooled to -78 °C  and added with 43 μL DAST (0.30 mmol, 1.2 eq). The 
reaction was stirred in dry ice for 12 hours. The reaction mixture was then added with 5 mL 
saturated sodium bicarbonate and extracted with dichloromethane (3 x 15 mL). The organic 
phases were then dried over anhydrous MgSO4 and evaporated under reduced pressure. 
Purification of the resulting oil by silica gel chromatography (5% ethyl acetate : 95% 
hexane) afforded 19c (34 mg, 75% yield, pale yellow oil) in 74% ee, as determined by 
chiral GC analysis. 1H-NMR (300 MHz, CDCl3): δ 3.75 (s, 3H), δ 5.77 (d, J= 48 Hz, 
1H, -CHF), δ 7.37-7.46 (m, 5H); 13C-NMR (75 MHz, CDCl3): δ 52.8, δ 89.5 (d, J= 
184.5 Hz), δ 126.8, δ 126.9, δ 129.0, δ 129.9, δ 134.4 (d, J= 34.5 Hz), δ 169.0. 19F-
NMR (282 MHz, CDCl3): δ -180.29 (d, J= 48.7 Hz). HRMS (EI+): exact mass 
calculated for C9H9FO2 requires m/z 168.0587, found 168.0594. Chiral GC analyses 
were carried out using a Shimadzu GC-17A gas chromatograph, FID detector, Agilent 
Cyclosilb column (30 m x 0.52 mm x 0.25 μm film) and the following separation 
program: 300 °C inlet, 300 °C detector, 100 °C oven, 2 °C/min gradient to 200 °C, 
50 °C/min gradient to 250 °C, and 250 °C for 2 min. An enantiomeric excess of 74% 
was estimated based on peak areas (see Supplementary Figure 5). 
 
Conversion of 20a to 20c. 100 mg (0.61 mmol) 20a were dissolved in 500 μL ethanol 
and added to 250 mL 100 mM KPi buffer pH 8.0. var-B4 was added to the mixture at a 
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final concentration of 2 μM. The mixture was added with a cofactor regeneration 
solution containing 0.5 mM NADPH, 30 mM glucose-6-phosphate and 1 U/mL 
glucose-6-phosphate dehydrogenase (final concentrations). The reaction mixtures were 
stirred at room temperature and extracted with chloroform (3 x 100 mL) after 3 hours. 
The organic phases were collected, dried over anhydrous MgSO4, and evaporated under 
reduced pressure. Purification of the resulting oil by silica gel chromatography (5% 
ethyl acetate : 95% hexane) afforded 20b (72 mg, 66%). 72 mg (0.4 mmol) of 20b and a 
catalytic amount (3 drops) of ethanol were dissolved in 2 mL dry dichloromethane 
under argon. The solution was cooled to -78 °C and added with 61 μL DAST (0.43 
mmol, 1.2 eq). The reaction was stirred in dry ice for 12 hours. The reaction mixture 
was then added with 5 mL saturated sodium bicarbonate and extracted with 
dichloromethane (3 x 15 mL). The organic phases were collected, dried over anhydrous 
MgSO4 and evaporated under reduced pressure. Purification of the resulting oil by silica 
gel chromatography (5% ethyl acetate : 95% hexane) afforded 20c (57 mg, 78% yield, 
pale yellow oil) in 72% ee, as determined by chiral GC analysis. 1H-NMR (300 MHz, 
CDCl3): δ 1.24 (t, J= 7.2 Hz, 3H, -CH3), δ 4.16-4.27 (m, 2H, -OCH2), δ 5.75 (d, J= 48 
Hz, 1H, -CHF), δ 7.37-7.46 (m, 5H); 13C-NMR (75 MHz, CDCl3): δ 14.2, δ 62.0, δ 
81.2, δ 89.6 (d, J= 184.5 Hz),  δ 126.8,  δ 126.9,  δ 128.9,  δ 129.8,  δ 134.4 (d, J= 34.5 
Hz), δ 169.0. 19F-NMR (282 MHz, CDCl3): δ -180.27 (d, J= 48.7 Hz). HRMS (EI+): 
exact mass calculated for C10H11FO2 requires m/z 182.0743, found 182.0750. Chiral GC 
analyses were carried out using a Shimadzu GC-17A gas chromatograph, FID detector, 
Agilent Cyclosilb column (30 m x 0.52 mm x 0.25 μm film) and the following 
separation program: 300 °C inlet, 300 °C detector, 100 °C oven, 2 °C/min gradient to 
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200 °C, 50 °C/min gradient to 250 °C, and 250 °C for 2 min. An enantiomeric excess of 
72% was estimated based on peak areas (see Supplementary Figure 5). 
 
Conversion of 21a to 21c. 95 mg (0.45 mmol) 21a were dissolved in 500 μL ethanol 
and added to 250 mL 100mM KPi buffer pH 8.0. Var-C12 was added to the mixture at a 
final concentration of 1 μM. The mixture was added with a cofactor regeneration 
solution containing 0.5 mM NADPH, 30 mM glucose-6-phosphate and 1 U/mL 
glucose-6-phosphate dehydrogenase (final concentrations). The reaction mixtures were 
stirred at room temperature and extracted with chloroform (3 x 100 mL) after 4 hours.  
The organic phases were collected, dried over anhydrous MgSO4, and evaporated under 
reduced pressure. Purification of the resulting oil by silica gel chromatography (5% 
ethyl acetate : 95% hexane) afforded 21b (71 mg, 75%). 70 mg (0.34 mmol) of 21b and 
a catalytic amount (3 drops) of ethanol were dissolved in 2 mL dry dichloromethane 
under argon. The solution was cooled to -78 °C and added with 64 μL DAST (0.45 
mmol, 1.5 eq). The reaction was stirred in dry ice for 12 hours. The reaction mixture 
was then added with 5 mL saturated sodium bicarbonate and extracted with 
dichloromethane (3 x 15 mL). The organic phases were collected, dried over anhydrous 
MgSO4, and evaporated under reduced pressure. Purification of the resulting oil by flash 
chromatography (5% ethyl acetate : 95% hexane) afforded 21c (63 mg, 82% yield, 
colorless oil) in 89% ee, as determined by chiral GC analysis. 1H-NMR (300 MHz, 
CDCl3): δ 0.85 (t, J= 7 Hz, 3H, -CH3), δ 1.56-1.68 (m, 2H, CH2), δ 4.12 (t, J= 6 Hz, 2H, 
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-OCH2), δ 5.72 (d, J= 48 Hz, 1H, -CHF), δ 7.32 (br, 3H), δ 7.44 (br, 1H). 13C-NMR (75 
MHz, CDCl3): δ 10.3, δ 21.9, δ 67.7, δ 88.7 (d, J= 186.5 Hz), δ 124.8,  δ 126.9,  δ 
129.9,  δ 130.3,  δ 134.9. 19F-NMR (282 MHz, CDCl3): δ -182.8 (d, J= 48.7 Hz). HRMS 
(EI+): exact mass calculated for C11H12ClFO2 requires m/z 230.0510, found 230.0502. 
Chiral GC analyses were carried out using a Shimadzu GC-17A gas chromatograph, 
FID detector, Agilent Cyclosilb column (30 m x 0.52 mm x 0.25 μm film) and the 
following separation program: 300 °C inlet, 300 °C detector, 100 °C oven, 2 °C/min 
gradient to 200 °C, 50 °C/min gradient to 250 °C, and 250 °C for 2 min. An 
enantiomeric excess of 89% was estimated based on peak areas (see Supplementary 
Figure 6). 
 
Conversion of 22a to 22c. 100 mg (0.52 mmol) of 22a were dissolved in 500 μL 
ethanol and added to 250 mL 100 mM KPi buffer pH 8.0. Var-C12 was added to the 
mixture at a final concentration of 1 μM. The mixture was added with a cofactor 
regeneration solution containing 0.5 mM NADPH, 30 mM glucose-6-phosphate and 1 
U/mL glucose-6-phosphate dehydrogenase (final concentrations). The reaction mixtures 
were stirred at room temperature and extracted with chloroform (3 x 100 mL) after 4 
hours. The organic phases were collected, dried over anhydrous MgSO4, and evaporated 
under reduced pressure. Purification of the resulting oil by silica gel chromatography 
(5% ethyl acetate : 95% hexane) afforded 22b (78 mg, 65%). 78 mg (0.37 mmol) of 22b 
and a catalytic amount (3 drops) of ethanol were dissolved in 4 mL dry dichloromethane 
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under argon. The solution was cooled to -78 °C and added with 63 μL DAST (0.44 
mmol, 1.5 eq). The reaction was stirred in dry ice for 12 hours. The reaction mixture 
was then added with 5 mL saturated sodium bicarbonate and extracted with 
dichloromethane (3 x 15 mL). The organic phases were collected, dried over anhydrous 
MgSO4, and evaporated under reduced pressure. Purification of the resulting oil by flash 
chromatography (5% ethyl acetate : 95% hexane) afforded 22c (68 mg, 88%, colorless 
oil) in 85% ee, as determined by chiral GC analysis. 1H-NMR (300 MHz, CDCl3): δ 
0.83 (t, J= 7.5 Hz, 3H, -CH3), δ 1.52-1.68 (m, 2H, CH2), δ 2.43 (s, 3H, -CH3), δ 4.12 
(m, 2H, -OCH2), δ 5.96 (d, J= 48 Hz, 1H, -CHF), δ 7.16-7.30 (m, 4H); 13C-NMR (75 
MHz, CDCl3): δ 10.3, δ 19.3, δ 22.0, δ 29.9, δ 67.4, δ 87.4 (d, J= 183 
Hz), δ 126.5, δ 127.5, δ 129.8, δ 131.0. 19F-NMR (282 MHz, CDCl3): δ -180.1 (d, J= 
48.7 Hz). HRMS (EI+): exact mass calculated for C12H15FO2 requires m/z 210.1056, 
found 210.1070. Chiral GC analyses were carried out using a Shimadzu GC-17A gas 
chromatograph, FID detector, Agilent Cyclosilb column (30 m x 0.52 mm x 0.25 μm 
film) and the following separation program: 300 °C inlet, 300 °C detector, 100 °C oven, 
2 °C/min gradient to 200 °C, 50 °C/min gradient to 250 °C, and 250 °C for 2 min. An 
enantiomeric excess of 85% was estimated based on peak areas (see Supplementary 
Figure 6). 
 
Conversion of 23a to 23c. 100 mg (0.52 mmol) of 23a were dissolved in 500 μL 
ethanol and added to 250 mL 100mM KPi buffer pH 8.0. Var-C12 was added to the 
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mixture at a final concentration of 1 μM. The mixture was added with a cofactor 
regeneration solution containing 0.5 mM NADPH, 30 mM glucose-6-phosphate and 1 
U/mL glucose-6-phosphate dehydrogenase (final concentrations). The reaction mixtures 
were stirred at room temperature and extracted with chloroform (3 x 100 mL) after 4 
hours. The organic phases were collected, dried over anhydrous MgSO4, and evaporated 
under reduced pressure. Purification of the resulting oil by silica gel chromatography 
(5% ethyl acetate : 95% hexane) afforded 23b (70 mg, 65%). 70 mg (0.34 mmol) of 23b 
and a catalytic amount (3 drops) of ethanol were dissolved in 4 mL dry dichloromethane 
under argon. The solution was cooled to -78 °C and added with 58 μL DAST (0.4 
mmol, 1.5 eq). The reaction was stirred in dry ice for 12 hours. The reaction mixture 
was then added with 5 mL saturated sodium bicarbonate and extracted with 
dichloromethane (3 x 15 mL). The organic phases were collected, dried over anhydrous 
MgSO4, and evaporated under reduced pressure. Purification of the resulting oil by flash 
chromatography (5% ethyl acetate : 95% hexane) afforded 23c (59 mg, 83%, colorless 
oil) in 87% ee, as determined by chiral GC analysis. 1H-NMR (300 MHz, CDCl3): δ 
0.84-0.91 (m, 3H, -CH3), δ 1.57-1.68 (m, 2H, CH2), δ 2.37 (s, 3H, -CH3), δ 4.08-4.16 
(m, 2H, -OCH2), δ 5.75 (d, J= 48 Hz, 1H, -CHF), δ 7.18-7.27 (m, 2H), δ 7.27-7.44 (m, 
2H); 13C-NMR (75 MHz, CDCl3): δ 10.4, δ 19.4, δ 22.1, δ 29.9, δ 67.5, δ 87.2 (d, J= 
185 Hz), δ 126.5, δ 131.1. 19F-NMR (282 MHz, CDCl3): δ -178.5 (d, J= 48.7 Hz). 
HRMS (EI+): exact mass calculated for C12H15FO2 requires m/z 210.1056, found 
210.1062. Chiral GC analyses were carried out using a Shimadzu GC-17A gas 
chromatograph, FID detector, Agilent Cyclosilb column (30 m x 0.52 mm x 0.25 μm 
film) and the following separation program: 300 °C inlet, 300 °C detector, 100 °C oven, 
2 °C/min gradient to 200 °C, 50 °C/min gradient to 250 °C, and 250 °C for 2 min. An 
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enantiomeric excess of 87% was estimated based on peak areas (see Supplementary 
Figure 6). 
 
Conversion of 24 to 26. 103 mg (0.5 mmol) 24 were dissolved in 2 mL DMSO and 
added to 200 mL potassium phosphate buffer pH 8.0. The solution was added with var-
H1 (final conc.: 2.5 μM) and a cofactor regeneration system (final conc.: 500 μM 
NADPH, 30 mM glucose-6-phosphate, 2 units/mL glucose-6-phosphate dehydrogenase) 
and stirred at room temperature. After 48 hours, the reaction mixture was extracted with 
dichloromethane (4 x 70 mL). The combined organic phases were dried over anhydrous 
Na2SO4 and evaporated under reduced pressure. The residue was purified by flash 
chromatography (20% ethyl acetate: 80% hexane) to afford 25 (88 mg, 92%, colorless 
oil). 1H-NMR (300 MHz, CDCl3): δ 2.08 (s, 3H, CH3), δ 3.65 (dt, J=11.7, 3.6 Hz, 1H), δ 
3.85-3.92 (m, 2H), δ 5.34 (d, J= 7.8 Hz, 1H), δ 7.26-7.40 (m, 5H). 13C-NMR (75 MHz, 
CDCl3): δ 14.22, δ 56.83, δ 63.18, δ 83.27, δ 125.99, δ 128.50, δ 129.12, δ 140.58, δ 
166.60. HRMS (EI+): exact mass calculated for C11H13NO2 requires m/z 191.0946, 
found 191.0943. 88 mg (0.46 mmol) 25 and a catalytic amount (3 drops) of ethanol 
were dissolved in 3 mL dry dichloromethane under argon. The solution was placed in 
ice. After ten minutes, 66 μL DAST (0.46 mmol, 1 eq) were added to the mixture in 
aliquots of 22 μL every 30 minutes. The reaction was stirred in ice overnight. The 
reaction mixture was added with 5 mL saturated sodium bicarbonate and extracted with 
dichloromethane (3 x 15 mL). The organic phase was then dried over anhydrous 
magnesium sulfate and evaporated under reduced pressure. The residue was purified by 
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flash chromatography (gradient 10 to 30% ethyl acetate in hexane) to afford 26 (35 mg, 
40% yield, colorless oil). 1H-NMR (300 MHz, CDCl3): δ 2.12 (s, 3H, CH3), δ 4.2 (m, 
1H), δ 4.57 (dm, J= 47.4 Hz, 2H), δ 5.35 (d, J= 7.2 Hz, 1H), δ 7.25-7.40 (m, 5H). 13C-
NMR (75 MHz, CDCl3): δ 14.39, δ 60.64, δ 82.34 (d, J= 19.6 Hz), δ 83.92 (d, J= 155.7 
Hz) δ 125.74 (2C), δ 128.72, δ 129.14 (2C), δ 140.34, δ 166.50. 19F-NMR (282 MHz, 
CDCl3): δ -230.8 (dt, J=24.2, 45.1 Hz). HRMS (EI+): exact mass calculated for 
C11H12FNO requires m/z 193.0903, found 193.0917. 
 
Conversion of 27a to 27c. To a solution containing potassium phosphate buffer pH 8.0 
and 0.5 mM 27a in 1% DMSO was added with var-G5 (final conc.: 5 μM), 1 mg/mL 
bovine serum albumin (BSA), 1000 U/mL catalase, 4.1 U/mL superoxide dismutase 
(SOD) and a cofactor regeneration system (final conc.: 500 μM NADPH, 30 mM 
glucose-6-phosphate, 2 units/mL glucose-6-phosphate dehydrogenase). The reaction 
was stirred for 48 hours at 4 °C then worked-up as described above (e.g. compound 16). 
The residue was purified by flash chromatography (33% ethyl acetate: 67% hexanes, 
then 50% ethyl acetate: 50% hexanes) to afford 27b (60%, colorless oil). 1H-NMR (300 
MHz, CDCl3): δ 2.2 (m, 3H), δ 2.51 (d J=17.1, 1H), δ 2.76 (m, 2H), δ 3.30 (s, 3H), δ 
3.60 (d, J=5.7, 2H), δ 3.75 (q, J= 4.8 Hz, 1H), δ 4.96 (m, 1H). 13C-NMR (75 MHz, 
CDCl3): δ 26.14, δ 27.4, δ 30.8, δ 48.73, δ 52.09, δ 60.40, δ 73.24, δ 85.57, δ 200.18. 
HRMS (EI+): exact mass calculated for C9H14O4 requires m/z 186.0892, found 
186.0885. 14 mg (0.075 mmol) 27b were dissolved in 3 mL of dry dichloromethane and 
2.5 µL of dry ethanol were added. The mixture was cooled to -80 °C and 15 µL DAST 
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(0.11 mmol, 1.5 eq) were added. The reaction was allowed to come to room temperature 
slowly (16 h) and then quenched by addition of 3 mL of saturated NaHCO3 solution. 
The mixture was extracted with dichloromethane (4 x 15 mL), the organic phases were 
collected, dried over anhydrous magnesium sulfate, and evaporated under reduced 
pressure. The residue was purified by flash chromatography (20% ethyl acetate : 80% 
hexanes, then 33% ethyl acetate: 67% hexanes) to afford 27c (9.4 mg, 66% yield, 
colorless oil). 1H-NMR (300 MHz, CDCl3): δ 2.21 (m, 2H), δ 2.52 (m, 1H), δ 2.81 (m, 
2H), δ 3.30 (s, 3H), δ 3.78 (q, J= 7.2, 1H), δ 4.40 (ddd, J= 47.4, 24.6, 9.6 Hz, 1H, CHF), 
δ 4.41 (ddd, J= 47.4, 24.6, 9.6 Hz, 1H, CHF), δ 5.00 (m, 1H). 13C-NMR (75 MHz, 
CDCl3): δ 27.05, δ 35.68, δ 36.85, δ 39.28, δ 52.98 (d, J= 18.3 Hz), δ 56.83, δ 83.18 (d, 
J= 139 Hz), δ 84.51, δ 179.29. 19F-NMR (282 MHz, CDCl3): δ -225.8 (td, J= 48.2, 27.1 
Hz). HRMS (EI+): exact mass calculated for C9H13FO3 requires m/z 188.0849, found 
188.0817. 
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Conversion of 28a to 28c. To a solution containing potassium phosphate buffer pH 8.0 
and 1 mM 28a in 1% DMSO was added with var-B3 (final conc.: 5 μM) and a cofactor 
regeneration system (final conc.: 500 μM NADPH, 30 mM glucose-6-phosphate, 2 
units/mL glucose-6-phosphate dehydrogenase). The reaction was stirred for 48 hours at 
room temperature, then worked-up as described above. The residue was purified by 
flash chromatography (25% ethyl acetate: 75% hexanes, then 33% ethyl acetate: 67% 
hexanes) to afford 28b (75%, white powder). LC-MS (m/z): [M+H]+  279.0. 1H and 13C 
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NMR data were identical to those of the authentic standard. Two reaction vessels were 
prepared dissolving, under argon, 30 mg (0.11 mmol) 28b in 3 mL dry dichloromethane 
in each vessel. 18.5 μL DAST (0.13 mmol, 1.2 eq) were added each vessel in aliquots of 
6 μL aliquots every 30 minutes. The reaction was stirred at room temperature. After 4 
hours, the reaction mixture was added with 5 mL saturated sodium bicarbonate and 
extracted with dichloromethane (3 x 15 mL). The organic phases were collected, dried 
over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue 
was purified by flash chromatography (20% ethyl acetate : 80% hexane) to afford 28c 
(33 mg, 55% yield, white powder). 1H-NMR (300 MHz, CDCl3): δ 2.50 (m, 4H), δ 2.96 
(m, 2H), δ 4.54 (ddd, J= 47.4, 21.0, 9.6 Hz, 1H, CHF), δ 4.55 (ddd, J= 47.4, 21.0, 9.6 
Hz, 1H, CHF), δ 5.12 (m, 1H), δ 5.41 (m, 1H), δ 7.44 (m, 2H), δ 7.56 (m, 1H), δ 8.01 
(m, 2H). 13C-NMR (75 MHz, CDCl3): δ 36.20, δ 38.97, δ 40.30, δ 53.66 (d, J= 18.5 
Hz), δ 73.16, δ 83.62 (d, J= 170 Hz), δ 84.92, δ 128.79, δ 129.89, δ 133.66, δ 166.22, δ 
176.46. 19F-NMR (282 MHz, CDCl3): δ -226.7 (td, J= 48.0, 30.1 Hz). HRMS (EI+): 
exact mass calculated for C15H16FO4 requires m/z 279.1033, found 279.1041. 
 
Conversion of 29a to 29c. To a solution containing potassium phosphate buffer pH 8.0 
and 0.5 mM 29a in 1% DMSO was added var-H1 (final conc.: 5 μM), 1 mg/mL BSA, 
1000 U/mL catalase, 4.1 U/mL SOD and a cofactor regeneration system (final conc.: 
500 μM NADPH, 30 mM glucose-6-phosphate, 2 units/mL glucose-6-phosphate 
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dehydrogenase). The reaction was stirred for 48 hours at room temperature, then 
worked-up as described above (e.g. compound 16). The residue was purified by flash 
chromatography (25% ethyl acetate: 75% hexanes, then 50% ethyl acetate: 50% 
hexanes) to afford 29b (60%, colorless oil). LC-MS (m/z): [M+H]+  355.0. 1H and 13C 
NMR data were identical to those of the authentic standard. Two reaction vessels were 
prepared dissolving, under argon, 20 mg (0.05 mmol) 29b in 2 mL dry dichloromethane 
in each vessel. 10 μL DAST (0.07 mmol, 1.2 eq) were added to each vessel in aliquots 
of 3 μL aliquots every 30 minutes. The reaction was stirred at room temperature. After 6 
hours, the reaction mixture was added with 5 mL saturated sodium bicarbonate and 
extracted with dichloromethane (3 x 15 mL). The organic phases were collected, dried 
over anhydrous magnesium sulfate, and evaporated under reduced pressure. The residue 
was purified by flash chromatography (20% ethyl acetate : 80% hexane) to afford 29c 
(18 mg, 52% yield, white powder). 1H-NMR (300 MHz, CDCl3): δ 2.44 (m, 2H), δ 
2.50-2.61 (m, 2H), δ 2.95-3.02 (m, 2H), δ 4.48 (ddd, J= 47.1, 21.3, 11.7 Hz, 1H, CHF), 
δ 4.64 (ddd, J= 47.1, 21.3, 11.7 Hz, 1H, CHF), δ 5.15 (m, 1H), δ 5.44 (m, 1H), δ 7.35-
7.50 (m, 3H), δ 7.55-7.69 (m, 4H), δ 8.02-8.08 (m, 2H). 13C-NMR (75 MHz, CDCl3): δ 
36.26, δ 39.00, δ 40.28 (d, J= 4.27 Hz), δ 53.76 (d, J= 18.2 Hz), 83.77 (d, J= 183.9 Hz), 
δ 84.81, δ 127.45 (2C), δ 127.52 (2C), δ 128.35, δ 128.45, δ 129.17 (2C), δ 130.44 (2C), 
δ 140.08, δ 146.35, δ 166.11, δ 176.55. 19F-NMR (282 MHz, CDCl3): δ -226.6 (td, J= 
45.4, 30.2 Hz). HRMS (EI+): exact mass calculated for C21H20FO4 requires m/z 
355.1346, found 355.1332.  
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P450 expression and purification. For the chemo-enzymatic transformations, P450 
enzymes were used in purified form. Enzyme batches were prepared as follows. Two 
liters Terrific Broth medium were inoculated with an overnight culture (10 mL) of 
recombinant E. coli DH5α cells harboring a pCWori plasmid encoding for the P450 
variant under the control of Plac promoter. At OD600=1.1, cultures were added with 0.5 
mM IPTG and 0.5 mM δ-aminolevulinic acid (ALA) and transferred to 25˚C. Cells 
were harvested after 24 hours. The cell pellet was resuspended in 25 mM TRIS (pH 8.0) 
and cell membranes were disrupted by sonication. Cell lysate was loaded onto a Q resin 
and the column was washed with 3 column volumes of 25 mM TRIS (pH 8.0), 150 mM 
NaCl. Bound protein was eluted with 25 mM TRIS (pH 8.0), 340 mM NaCl and 
concentrated using Millipore Centricon. After buffer exchange with 100 mM KPi (pH 
8.0), protein samples were frozen and stored at -80 °C. Protein concentration was 
determined in duplicate from CO-difference spectra. Yields typically ranged between 
100 and 500 mg protein per liter depending on the variant.    
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